Evidence map›Paper›PMID 28736267›Full record

Trial reportThe Journal of allergy and clinical immunology2018

Gamma tocopherol-enriched supplement reduces sputum eosinophilia and endotoxin-induced sputum neutrophilia in volunteers with asthma.

Allison J Burbank, Charity G Duran, Yinghao Pan, Patricia Burns, Susan Jones, Qing Jiang, Chao Yang, Sha'Leema Jenkins, Heather Wells, Neil Alexis and 5 more

3 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03444298 phase2completednot on this map

A Phase II Randomized, Double Blinded, Placebo-controlled Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2018 to 2023Enrolled16ConditionsAirway Inflammation, AsthmaArmsGamma Tocopherol, Placebo
NCT03851406 nacompletednot on this mapstarted 2019, after this paper: background citation

Phase I/II Randomized Cross-over Study of Hypertonic Saline on Airway Inflammatory Response to Inhaled Wood Smoke

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2024Enrolled9ConditionsAirway InflammationArms5% Hypertonic Saline, No treatment
NCT03861390 phase1 / phase2completednot on this mapstarted 2019, after this paper: background citation

Phase I/II Randomized, Double-blind, Placebo-controlled Cross-over Study of Prednisone on Airway Inflammatory Response to Inhaled Wood Smoke

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2023Enrolled12ConditionsAirway InflammationArms60 mg Prednisone, Placebo
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Integrative analysis of the intestinal metabolome of childhood asthma.The Journal of allergy and clinical immunology · 2019
    Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Exploratory analysis of the impact of sex on sputum proteomic response to inhaled wood smoke in humans.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  11. Review
  12. TLR4Nature communications · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. AMPK activation coupling SENP1-Sirt3 axis protects against acute kidney injury.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Allison J BurbankCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC. Electronic address: allison_burbank@med.unc.edu.
Charity G DuranCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Yinghao PanDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
Patricia BurnsCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Susan JonesCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Qing JiangDepartment of Nutrition Science, Purdue University, West Lafayette, Ind.
Chao YangDepartment of Nutrition Science, Purdue University, West Lafayette, Ind.
Sha'Leema JenkinsCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Heather WellsCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Neil AlexisCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC.
Mehmet KesimerDepartment of Pathology and Laboratory Medicine, Cystic Fibrosis/Pulmonary Research and Treatment Center, Marsico Lung Institute, University of North Carolina, Chapel Hill, NC.
William D BennettCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC.
Haibo ZhouDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC.
David B PedenCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC.
Michelle L HernandezCenter for Environmental Medicine, Asthma and Lung Biology, University of North Carolina, Chapel Hill, NC; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC.
University of North Carolina at Chapel Hill · USPurdue University West Lafayette · USLung Institute · US

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
TOXICOLOGYT32ES007126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ILONA JASPERS, Bernard E. Weissman · 1985 to 2026
$13.0M
UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program-Evaluation SupplementT32GM086330 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KIM L.R. BROUWER, Daniel Gonzalez · 2011 to 2026
$8.5M
Phase II studies of gamma tocopherol as an intervention for environmental asthmaR01ES023349 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PEDEN, DAVID B. · 2013 to 2017
$3.7M
The role of mucin-protein interactions in the innate defense of the lungR01HL103940 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KESIMER, MEHMET · 2010 to 2014
$1.8M
Airway mucus/mucin composition and proteome in COPD: A SPIROMICS ancillary studyR01HL110906 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KESIMER, MEHMET · 2011 to 2014
$1.4M
Statistical Methods for Outcome-Dependent SamplingR01ES021900 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHOU, HAIBO · 2013 to 2016
$1.1M
Down-regulation of oxidant-induced airway inflammation though modulation of NRF2K23ES021745 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HERNANDEZ, MICHELLE · 2012 to 2014
$612k
NHLBI NIH HHS R01 HL103940NHLBI NIH HHS R01 HL110906NIEHS NIH HHS K23 ES021745NIEHS NIH HHS P30 ES010126NIEHS NIH HHS R01 ES021900NIEHS NIH HHS R01 ES023349NIEHS NIH HHS T32 ES007126NIGMS NIH HHS T32 GM086330
6 · The paper itself

Abstract

backgroundWe and others have shown that the gamma tocopherol (γT) isoform of vitamin E has multiple anti-inflammatory and antioxidant actions and that γT supplementation reduces eosinophilic and endotoxin (LPS)-induced neutrophilic airway inflammation in animal models and healthy human volunteers.

objectiveWe sought to determine whether γT supplementation reduces eosinophilic airway inflammation and acute neutrophilic response to inhaled LPS challenge in volunteers with asthma.

methodsParticipants with mild asthma were enrolled in a double-blinded, placebo-controlled crossover study to assess the effect of 1200 mg of γT daily for 14 days on sputum eosinophils, mucins, and cytokines. We also assessed the effect on acute inflammatory response to inhaled LPS challenge following γT treatment, focusing on changes in sputum neutrophilia, mucins, and cytokines. Mucociliary clearance was measured using gamma scintigraphy.

resultsFifteen subjects with mild asthma completed both arms of the study. Compared with placebo, γT notably reduced pre-LPS challenge sputum eosinophils and mucins, including mucin 5AC and reduced LPS-induced airway neutrophil recruitment 6 and 24 hours after challenge. Mucociliary clearance was slowed 4 hours postchallenge in the placebo group but not in the γT treatment group. Total sputum mucins (but not mucin 5AC) were reduced at 24 hours postchallenge during γT treatment compared with placebo.

conclusionsWhen compared with placebo, γT supplementation for 14 days reduced inflammatory features of asthma, including sputum eosinophils and mucins, as well as acute airway response to inhaled LPS challenge. Larger scale clinical trials are needed to assess the efficacy of γT supplements as a complementary or steroid-sparing treatment for asthma.

Indexed as

AdultAsthmaBiomarkersCross-Over StudiesDouble-Blind MethodDrug Administration ScheduleEndotoxinsEosinophiliaEosinophilsFemalegamma-TocopherolHumansMaleMiddle AgedMucinsNeutrophil InfiltrationBiomarkersEndotoxinsgamma-TocopherolMucinsVitaminsAsthmaendotoxineosinophillipopolysaccharidemucinmucociliary clearanceneutrophiltocopherolvitamin E

Identifiers

PMID28736267
PMCPMC5775926
OpenAlexW2738464462

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.